Embecta (Embecta) FCF Margin % : -5.70% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Embecta FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Embecta's Free Cash Flow for the three months ended in Dec. 2023 was $-16 Mil. Embecta's Revenue for the three months ended in Dec. 2023 was $277 Mil. Therefore, Embecta's FCF Margin % for the quarter that ended in Dec. 2023 was -5.70%.

As of today, Embecta's current FCF Yield % is -5.14%.

The historical rank and industry rank for Embecta's FCF Margin % or its related term are showing as below:

EMBC' s FCF Margin % Range Over the Past 10 Years
Min: -2.7 Med: 35.79 Max: 42.06
Current: -2.7

During the past 5 years, the highest FCF Margin % of Embecta was 42.06%. The lowest was -2.70%. And the median was 35.79%.

EMBC's FCF Margin % is ranked better than
55.39% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.12 vs EMBC: -2.70

Embecta FCF Margin % Historical Data

The historical data trend for Embecta's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta FCF Margin % Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Margin %

39.31

42.06

35.79

34.37

3.68

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial										20.20	-6.78	-5.63	7.24	-5.70

Competitive Comparison of Embecta's FCF Margin %

For the Medical Instruments & Supplies subindustry, Embecta's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Embecta's FCF Margin % falls into.

Embecta FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Embecta's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	41.2	/	1120.8
	=	3.68 %

Embecta's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-15.8	/	277.3
	=	-5.70 %

Embecta FCF Margin % Related Terms

Thank you for viewing the detailed overview of Embecta's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (Embecta) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Executives

David F Melcher	director	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Devdatt Kurdikar	officer: President and CEO	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze	officer: Chief Financial Officer	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann	officer: SVP, GC, Head Corp. Dev., Secy	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner	officer: Chief Human Resources Officer	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar	officer: SVP and CHRO	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis	officer: SVP, Global Manuf./Sup. Chain	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton	director	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Brian Capone	officer: VP, CAO & Corp. Controller	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson	director	3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach	director	C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015